FDBC Q4 2025 Earnings Solid EPS Performance Amidst Limited Guidance Recursion Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates Amid Pipeline Progress GOOG Q1 2026 Earnings EPS Misses Estimates as Cloud and AI Costs Weigh RDNW Q1 2026 Earnings EPS Surprises to the Upside Despite Revenue NonDisclosure FTAIM Q1 2026 Earnings EPS Falls Short of Estimates Preferred Shares Unchanged ITT Q1 2026 Earnings EPS Beat Fails to Impress Shares Dip 248